A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia C. U. CorrellOfer AgidOliver D. Howes Therapy in Practice Open access 27 June 2022 Pages: 659 - 679
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment Mario Gennaro MazzaMariagrazia PalladiniFrancesco Benedetti Review Article 21 June 2022 Pages: 681 - 702
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis Stanley L. CohanRalph H. B. BenedictJerold Chun Review Article Open access 20 June 2022 Pages: 703 - 719
Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder Christoff GeldenhuysLeigh L. van den HeuvelSoraya Seedat Review Article 10 June 2022 Pages: 721 - 737
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs Andrew LoftsFahed Abu-HijlehTodd Hoare Review Article 27 June 2022 Pages: 739 - 770
The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials Erin G. DotyPaula M. HauckRichard B. Lipton Original Research Article Open access 02 July 2022 Pages: 771 - 783
Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications Yves DauvilliersKarel ŠonkaMichael J. Thorpy Correction Open access 28 June 2022 Pages: 785 - 786